Author:
Cornetta Kenneth,Duffy Lisa,Feldman Steven A.,Mackall Crystal L.,Davila Marco L.,Curran Kevin J.,Junghans Richard P.,Tang Jean Yuh,Kochenderfer James N.,O’Cearbhaill Roisin,Archer Gary,Kiem Hans-Peter,Shah Nirali N.,Delbrook Cindy,Kaplan Rosie,Brentjens Renier J.,Rivière Isabelle,Sadelain Michel,Rosenberg Steven A.
Funder
NHLBI
NCI Intramural Funding
NIH/NCI
NIH
St. Baldrick's Foundation
William Lawrence and Blanche Hughes Foundation
Carson Family Charitable Trust
Annual Terry Fox Run for Cancer Research
Canada Club of New York, Kate’s Team
Subject
Genetics,Molecular Biology,Molecular Medicine
Reference34 articles.
1. Glaxo Smith Kline (2016). StrimvelisTM receives European marketing authorisation to treat very rare disease, ADA-SCID. https://us.gsk.com/en-us/media/press-releases/2016/strimvelistm-receives-european-marketing-authorisation-to-treat-very-rare-disease-ada-scid/.
2. U.S. Food and Drug Administration (2017). FDA approves CAR-T cell therapy to treat adults with certain types of large B-cell lymphoma. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm581216.htm.
3. Safety issues related to retroviral-mediated gene transfer in humans;Cornetta;Hum. Gene Ther.,1991
4. Analysis of retroviral packaging lines for generation of replication-competent virus;Muenchau;Virology,1990
5. Development of a high-titer retrovirus producer cell line capable of gene transfer into rhesus monkey hematopoietic stem cells;Bodine;Proc. Natl. Acad. Sci. USA,1990
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献